Literature DB >> 28741397

Survival and prognostic factors at time of diagnosis in high-grade appendicular osteosarcoma: a 21 year single institution evaluation from east Denmark.

Thomas Colding-Rasmussen1, Andrea Pohly Thorn1, Peter Horstmann1, Catherine Rechnitzer2, Lisa Lyngsie Hjalgrim2, Anders Krarup-Hansen3, Michael Mørk Petersen1.   

Abstract

BACKGROUND: Survival of patients with high-grade osteosarcoma (HOS), the most common primary bone cancer, has not improved significantly the last 30 years and the disease remains a major challenge. The purpose of this study is to evaluate survival in relation to prognostic factors at time of diagnosis among patients diagnosed with primary appendicular HOS in East Denmark between 1990 and 2010.
MATERIAL AND METHODS: 101 patients (median age = 20 years, female/male ratio = 56/45) diagnosed with primary appendicular high-grade osteosarcoma between 1990 and 2010 were included in this study. Initially, 156 patients diagnosed with osteosarcoma between 1990 and 2010 were identified through the population based Regional Database of Pathology, which covers a population of approximately 2.7 million (east Denmark). 55 patients were excluded due to (A) tumor was low grade (n = 22), (B) located in axial skeleton (n = 18), (C) incorrect diagnosis (n = 11) or (D) biopsy represented a tumor relapse from a former primary osteosarcoma (n = 4). Overall survival was evaluated using the Kaplan-Meier survival analysis and log-rank test. Prognostic factors were analyzed using uni- and multivariate cox-regression method with variables scored equally in the model. p Values <.05 were considered statistically significant.
RESULTS: The probability of 5- and 10-year survival was 51% (95% CI: 41-61) and 46% (95% CI: 36-56), respectively. Metastatic stage at diagnosis and tumor size ≥10 cm measured radiologically at the largest diameter were independent prognostic factors for decreased survival with significant increased hazard-risks of 3.5 (95% CI: 1.9-6.5) and 1.97 (95% CI: 1.1-3.6), respectively. DISCUSSION: In this single institution evaluation of primary appendicular HOS we found 5-and 10-year survival rates consistent with international standards for this patient group. Distant metastases and tumor size ≥10 cm at the time of diagnosis were independent prognostic factors for decreased survival in our cohort. These results underline the importance of awareness and early referral from the primary sector.

Entities:  

Mesh:

Year:  2017        PMID: 28741397     DOI: 10.1080/0284186X.2017.1351620

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  4 in total

1.  Prognosis of Primary Osteosarcoma in Elderly Patients: A Comparison between Young and Elderly Patients.

Authors:  Hiroyuki Tsuchie; Makoto Emori; Hiroyuki Nagasawa; Naohisa Miyakoshi; Yasutaka Murahashi; Junya Shimizu; Emi Mizushima; Toshihiko Yamashita; Yoichi Shimada
Journal:  Med Princ Pract       Date:  2019-04-17       Impact factor: 1.927

2.  Impact of Primary Tumor Resection on Metastasis to the Lung in Patients With Bone and Soft-tissue Sarcoma.

Authors:  Hiroyuki Tsuchie; Makoto Emori; Hiroyuki Nagasawa; Yasutaka Murahashi; Emi Mizushima; Junya Shimizu; Toshihiko Yamashita; Naohisa Miyakoshi
Journal:  In Vivo       Date:  2021 Nov-Dec       Impact factor: 2.155

3.  Prognostic factors for survival among patients with primary bone sarcomas of small bones.

Authors:  Zhan Wang; Shu Li; Yong Li; Nong Lin; Xin Huang; Meng Liu; Weibo Pan; Xiaobo Yan; Lingling Sun; Hengyuan Li; Binghao Li; Hao Qu; Yan Wu; Peng Lin; Zhaoming Ye
Journal:  Cancer Manag Res       Date:  2018-05-14       Impact factor: 3.989

4.  Antibiotic Elution Characteristics and Pharmacokinetics of Gentamicin and Vancomycin from a Mineral Antibiotic Carrier: An in vivo Evaluation of 32 Clinical Cases.

Authors:  Thomas Colding-Rasmussen; Peter Horstmann; Michael Mørk Petersen; Werner Hettwer
Journal:  J Bone Jt Infect       Date:  2018-10-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.